ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0432072 | null | Dysmorphic features (finding)|dysmorphic features|Dysmorphic features | Dysmorphic features |
C0966503 | null | DNA, calf thymus | calf thymus DNA |
C0020261 | A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. | hydrochlorothiazide|Hydrochlorothiazidum|HCTZ|Dichlothiazide|Hydrochlorothiazide-containing product|Product containing hydrochlorothiazide (medicinal product)|hctz|HYDROCHLOROTHIAZIDE|2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide|Hidroclorotiazida|Hydrochlorothiazide (substance)|Dihydrochlorothiazide|Hydrochlorothiazide|6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide | hydrochlorothiazide |
C0053091 | A carboxyl-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, benazepril is metabolized to its active form benazeprilat. Benazeprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II resulting in vasodilation. Benazeprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow. | Benazepril|benazapril|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(R*,R*))-|Benazeprilum|Product containing benazepril (medicinal product)|Bénazépril|Benazepril-containing product|benzazepril|BENAZEPRIL|benazepril|Benazepril (substance) | benazepril |
C0105523 | The active metabolite of benazepril, a carboxyl-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Once the prodrug benazepril is metabolized to benazeprilat in the liver, benazeprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II, resulting in vasodilation. Benazeprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow. | benezaprilat|BENAZEPRILAT|benazeprilat|Benazeprilat | benazeprilat |
C0050456 | null | Acetonitrile (substance)|acetonitrile|Methyl cyanide|Acetonitrile | acetonitrile |
C0037982 | A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) | Spironolactone|Veroshpiron|Spirolactone|Verospirone|Spironolattone|Spironolactonum|SPIRONOLACTONE|SPL|17-hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic Acid, gamma Lactone, Acetate|spirolactone|Product containing spironolactone (medicinal product)|Spironolactone-containing product|Spironolactone (substance)|Espironolactona|spironolactone|spirolactones|Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, gamma-lactone, (7alpha,17alpha)-|17-Hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic Acid, gamma Lactone, Acetate | spironolactone |
C0006323 | The abundant submucosal mucous glands in the DUODENUM. These glands secrete BICARBONATE IONS; GLYCOPROTEINS; and PEPSINOGEN II. | Duodenal gland|Set of duodenal glands|brunner gland|Brunners Glands|Glands, Brunner's|Brunner's gland, NOS|Glandulae duodenales|mucous crypt (duodenum)|brunner's gland|Glands, Brunner|Duodenal glands|Brunner's Glands|brunner glands|Brunner Gland|brunners glands|Brunner's Gland|Duodenal glands set|duodenal gland|Brunner's gland|brunners gland|Gland of Brunner|GLAND, BRUNNER'S|brunner's glands|Brunner's glands|duodenal glands|Gland, Brunner | Brunner Glands |
C1516369 | Normal or pathologic migration and accumulation of cells within tissues. | Cellular Infiltration | Cellular Infiltration |
C0008672 | A specific pair of GROUP C CHROMSOMES of the human chromosome classification. | Chromosome pair 9|Chromosome 9|chromosome 9|Chromosome pair 9 (cell structure)|9 chromosome | Chromosomes, Human, Pair 9 |
C1136249 | A class of genetic disorders resulting in INTELLECTUAL DISABILITY that is associated either with mutations of GENES located on the X CHROMOSOME or aberrations in the structure of the X chromosome (SEX CHROMOSOME ABERRATIONS). | mental retardation x linked|x-linked mental retardation|Mental Retardation, X Linked|X-Linked Mental Retardation|X Linked Mental Retardation Disorders|X Linked Mental Retardation Syndromes|X-Linked Mental Retardations|Mental Retardation, X-Linked|Retardation, X-Linked Mental|X Linked Mental Retardation|x linked mental retardation|X-Linked Mental Retardation Syndromes|X-Linked Mental Retardation Disorders|MENTAL RETARDATION, X-LINKED|X-linked mental retardation | Mental Retardation, X-Linked |
C0400499 | null | Operation on pancreatic duct (procedure) | Operation on pancreatic duct |
C0400499 | null | Operation on pancreatic duct (procedure) | Operation on pancreatic duct |
C1321605 | Voluntary cooperation of the patient in following a prescribed regimen. | compliance (psychology)|Patient Cooperation|Patient Adherence|Adherence, Patient|therapy compliance|Patient Compliance|client compliance|Compliance behavior|Compliant|Cooperation, Patient|COMPLIANCE|Compliance behavior (observable entity)|Compliance|Compliance, Patient|Compliance behaviour|treatment compliance|Patient compliance|patient compliance|compliance | Compliance behavior |
C0086908 | Nucleotide sequences present in multiple copies in the genome. There are several types of repeated sequences. Interspersed (or dispersed) DNA repeats (Interspersed Repetitive Sequences) are copies of transposable elements interspersed throughout the genome. Flanking (or terminal) repeats (Terminal Repeat Sequences) are sequences that are repeated on both ends of a sequence, for example, the long terminal repeats (LTRs) on retroviruses. Direct terminal repeats are in the same direction and inverted terminal repeats are opposite to each other in direction. Tandem repeats (Tandem Repeat Sequences) are repeated copies which lie adjacent to each other. These can also be direct or inverted. The ribosomal RNA and transfer RNA genes belong to the class of middle repetitive DNA. | Repetitive Element|Repetitive Sequence|Repetitive Sequences|Repeated Sequence|Repetitive Regions | Repetitive Region |
C0728475 | null | null | ultra |
C1289975 | null | androgenic steroids|androgenic steroid | androgenic steroid |
C1565751 | null | 0431, MK|MK0431|MK-0431 | MK 0431 |
C0019381 | Members of the ROSEOLOVIRUS genus of the Betaherpesvirales subfamily isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter the activity of NK CELLS. HHV-6; (HBLV) antibodies are elevated in patients with AIDS; SJOGREN'S SYNDROME; SARCOIDOSIS; CHRONIC FATIGUE SYNDROME, and certain malignancies. HHV-6A is the most common cause of EXANTHEMA SUBITUM and has been implicated in encephalitis. When HHV-6 integrates into the host genome it is referred to as ciHVH-6. When such VIRUS INTEGRATION occurs into the germline it is referred to as iciHHV-6. | HHV-6|Roseola infantum virus|herpesvirus 6 HHV-6|Herpesvirus 6, Human|human herpes 6 virus|Human herpesvirus-6|Human herpes virus 6|human B lymphotropic virus|human herpes virus 6|Roseola virus|hhv 6|Human B Lymphotropic Virus|roseola virus|Human betaherpesvirus 6|6 herpes human virus|Human Herpesvirus 6|human herpesvirus type 6 HHV-6|Herpesvirus type 6|HHV6 - Human herpes virus 6|HHV6|Human herpesvirus type 6|HHV 6|human herpesvirus 6 HHV-6|herpes simplex virus type 6|B-Lymphotropic Virus, Human|Exanthem subitum virus|HBLV|Virus-HHV6|Human herpesvirus 6|hhv-6|hhv6|Human betaherpesvirus 6s|Human herpesvirus 6 (organism)|HUMAN HERPESVIRUS 6|Human B-Lymphotropic Virus|Human B-Lymphotropic Viruses|human herpesvirus 6|B-Lymphotropic Viruses, Human | herpesvirus 6, human |
C0025424 | A silver metallic element that exists as a liquid at room temperature. It has the atomic symbol Hg (from hydrargyrum, liquid silver), atomic number 80, and atomic weight 200.59. Mercury is used in many industrial applications and its salts have been employed therapeutically as purgatives, antisyphilitics, disinfectants, and astringents. It can be absorbed through the skin and mucous membranes which leads to MERCURY POISONING. Because of its toxicity, the clinical use of mercury and mercurials is diminishing. | hg|metal mercury|Hg|MERCURY|Liquid Silver|mercury|Hydrargyrum|Hg - Mercury|Mercury, NOS|Quicksilver|Mercury (substance)|Hg element|Mercury|mercury (Hg) | mercury |
C1517033 | Radiation therapy in which high-energy beams are delivered to the tumor from outside of the body. | external beam radiation therapy|EXTERNAL BEAM RADIATION THERAPY|external beam radiation|External Beam Radiotherapy|external radiation|External Beam Radiation Therapy|External Beam RT|external-beam radiation|External Radiation Therapy|EBRT|Definitive Radiation Therapy | External Beam Radiation Therapy |
C1305775 | null | Entire PV - Portal vein|Entire portal vein (body structure)|Entire portal vein | Entire portal vein |
C0600521 | A therapy using IONIZING RADIATION where there is improved dose homogeneity within the tumor and reduced dosage to uninvolved structures. The precise shaping of dose distribution is achieved via the use of computer-controlled multileaf collimators. | 3D conformal radiation therapy|Radiotherapy, 3-D Conformal|Conformal Radiotherapy, 3-D|Three dimensional conformal radiotherapy|3D CONFORMAL RADIATION THERAPY|Three-Dimensional Conformal Radiotherapy|Radiation Conformal Therapy|conformal radiotherapy|Conformal radiotherapy (procedure)|Conformal Radiotherapies|3-dimensional radiation therapy|Conformal Therapy|Three-Dimensional Conformal Radiotherapies|3D-CRT|3D CRT|3-D Conformal Radiotherapies|Radiotherapies, Three-Dimensional Conformal|Conformal radiotherapy|Three dimensional conformal radiotherapy (procedure)|3-Dimensional Conformal Radiation Therapy|Radiotherapies, Conformal|3-D Conformal Radiotherapy|Conformal Radiotherapy, Three-Dimensional|Three Dimensional Conformal Radiotherapy|Conformal Radiotherapy|Conformal Radiotherapies, Three-Dimensional|Conformal Radiotherapies, 3-D|Radiotherapy, Three-Dimensional Conformal|Radiotherapies, 3-D Conformal|3-dimensional conformal radiation therapy | Radiotherapy, Conformal |
C0013090 | A synthetic tetracycline derivative with similar antimicrobial activity. | Doxycycline-containing product|Doxiciclina|6alpha-deoxy-5-oxytetracycline|Product containing doxycycline (medicinal product)|doxycycline|Doxycycline|2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-|Alpha-6-Deoxyoxytetracycline|6α-deoxy-5-oxytetracycline|Doxycyclinum|6-alpha-deoxy-5-oxytetracycline|DOXYCYCLINE|5-hydroxy-α-6-deoxytetracycline|Alpha 6 Deoxyoxytetracycline|Doxycycline (substance)|Doxycyclin | doxycycline |
C0379214 | null | prospero protein|pro protein|prospero protein, Drosophila | pros protein, Drosophila |
C0324833 | A species of the genus MACACA inhabiting India, China, and other parts of southern Asia. The species is characterized by its thick brown fur covering most of its body except the face and short tail. | Macaque, Brown Stump-tailed|Stump-Tailed Macaque|Macacus brunneus|Macacus speciosus|Macacus ursinus|Stump Tailed Macaque|Macaque, Bear|bear macaque|Macaque, Stump-Tailed|Stump-tailed Macaque, Brown|Stump-Tailed Macaques|Stump-tailed macaque|M. speciosus|Bear Macaque|M. ursinus|Brown Stump tailed Macaque|Brown Stump-tailed Macaque|Macaca arctoides (organism)|M. brunneus|Macaca arctoides|Brown Stump-tailed Macaques|M. arctoides|Bear Macaques | Macaca arctoides |
C0009990 | Sexual union of a male and a female in non-human species. | Copulation|copulation|Copulation, NOS|Copulations | Copulation |
C0017324 | The process of formulating general concepts by abstracting common properties of instances; reasoning from detailed facts to general principles. | Psychology Generalization|Psychology Generalizations|Generalizations, Psychological|Psychological Generalization|generalization|Generalizations, Psychology|Generalizations (Psychology)|generalizations|Generalization (Psychology)|Generalization|Generalization, Psychology|Psychological Generalizations | Generalization, Psychological |
C1564907 | A large family of cell surface receptors that bind conserved molecular structures (PAMPS) present in pathogens. They play important roles in host defense by mediating cellular responses to pathogens. | Pattern Recognition Receptors | Receptors, Pattern Recognition |
C1510941 | An orderly arrangement. | null | Array |
C0005186 | null | actin beta|beta actin|beta Actin|beta-Actin | beta-Actin |
C0232976 | The process whose specific outcome is the progression of a spermatid over time, from its formation to the mature structure. [GOC:dph, GOC:go_curators] | Spermiogenesis, function (observable entity)|spermatid cell development|Spermiogenesis|Spermiogenesis, function|spermiogenesis|spermatid development | Spermiogenesis |
C0017472 | The three primary germinal layers (ECTODERM; ENDODERM; and MESODERM) developed during GASTRULATION that provide tissues and body plan of a mature organism. They derive from two early layers, hypoblast and epiblast. | Layers, Germ|Germ Layer|Germ layer|germ layer|Germ Layers|Layer, Germ | Germ Layers |
C0444930 | null | End|ending|end|End (qualifier value)|ends | End |
C0814992 | A narrow, elongated depression on the embryonic neural plate, located between the neural folds, that, when the neural folds unite at the midline, will deepen to form the neural canal. | Neural Groove|neural groove|Neural groove (body structure)|Groove, Neural|Neural Grooves|Neural groove|Grooves, Neural | Neural Groove |
C0039748 | The flattened stroma cells forming a sheath or theca outside the basal lamina lining the mature OVARIAN FOLLICLE. Thecal interstitial or stromal cells are steroidogenic, and produce primarily ANDROGENS which serve as precusors of ESTROGENS in the GRANULOSA CELLS. | Interstitial Cell, Ovarian|Cell, Theca|Cells, Ovarian Interstitial|Endocrinocytus interstitialis (Ovarium)|Interstitial cell of ovary|Cell, Ovarian Interstitial|Interstitial Cells, Ovarian|Cells, Theca|Theca Cells|theca cell|theca cells|Theca Cell|Ovarian Interstitial Cells|Ovarian Interstitial Cell | theca cell |
C0005027 | A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics. | Compounds, Benzalkonium | Benzalkonium Compounds |
C0046841 | null | benzoylbenzoyl-ATP|Bz-ATP|BzATP|3'-O-(4-benzoyl)benzoyl ATP|Adenosine 5'-(tetrahydrogen triphosphate), 3'-(4-benzoylbenzoate)|3'-O-(4-benzoylbenzoyl)ATP | 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate |
C0174492 | null | PPADS | pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid |
C1520795 | Proximal (short) arm of chromosome 18 | Chromosome 18 Proximal Arm|Chromosome 18 Short Arm|18p | Chromosome 18 Short Arm |
C0001866 | The dissociation of molecules in the air into positive and negative ions under the influence of an electric field. | air ionization|ionization air|Ionizations, Air|Ionization, Air|Air Ionizations | Air Ionization |
C0871908 | null | onset sleep | sleep onset |
C0040517 | A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or a another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79) | Gilles de la Tourette syndrome|Gilles de la Tourette's Disease|Tourette Disorder|tourette syndrome|SYNDROME TOURETTE|tic de Guinon|Tourette's Syndrome|Gilles de la Tourette's syndrome (disorder)|motor-verbal tic disorders|Tourettes Disorder|syndromes tourette|GILLES DE LA TOURETTE|tourette's syndrome|Combined Vocal and Multiple Motor Tic Disorder|Multiple Motor and Vocal Tic Disorder, Combined|tourettes disease|de gilles la tourette|gilles de la tourette's syndrome|Tourette Syndrome|Gilles de la Tourette's disorder|GTS|Gilles De La Tourette's Syndrome|Chronic Motor and Vocal Tic Disorder|Motor-verbal tic disorder|syndrome tourettes's|tourette's disorder|Tic Disorder, Combined Vocal and Multiple Motor|Tourette's syndrome|maladie des tics|GILLES DE LA TOURETTE SYNDROME|syndrome tourettes|Tourette Disease|TS|tourette's syndrome gilles de la|gilles de la tourette|Gilles de la Tourette's syndrome|Gilles de la Tourette Syndrome|syndrome tourette's|syndromes tourettes|Tourette's Disorder|gilles de la tourette syndrome|Tourette's Disease|Gilles de la Tourettes syndrome|TOURETTE SYNDROME|gilles de la tourette disorder|tourette disorder|de gilles la tourettes|Tourettes Disease|TOURETTE DISORDER|Combined vocal and multiple motor tic disorder|tourettes syndrome|Guinon's disease|Syndrome, Tourette|Tourettes Syndrome|syndrome tourette|disorder tourette|tourettes disorder|Tourette syndrome|Tourette's disorder|Combined Multiple Motor and Vocal Tic Disorder|tourette's disease|SYNDROME GILLES DE LA TOURETTE | Gilles de la Tourette syndrome |
C1155900 | The developmental growth process in which an oocyte irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present. [http://ovary.stanford.edu] | null | oocyte growth |
C1519449 | A cell that produces sperm. | null | Spermatogenic Cell |
C0034823 | Those protein complexes or molecular sites on the surfaces and cytoplasm of gonadal cells that bind luteinizing or chorionic gonadotropic hormones and thereby cause the gonadal cells to synthesize and secrete sex steroids. The hormone-receptor complex is internalized from the plasma membrane and initiates steroid synthesis. | Receptors, LH|hCG Receptor|Hormone Receptor, Luteinizing|Receptor, Chorionic Gonadotropin|LH hCG Receptors|Luteinizing Hormone Receptor|LH-hCG Receptors|Receptor, hCG|Luteinizing Hormone Receptors|Receptors, ICSH|Receptors, Interstitial Cell-Stimulating Hormone|Receptors, Chorionic Gonadotropin|Receptors, Interstitial Cell Stimulating Hormone|Receptors, Lutropin|Chorionic Gonadotropin Receptor|Receptors, Luteinizing Hormone|Receptors, Human Chorionic Gonadotropin|Lutropin Receptors|Gonadotropin Receptor, Chorionic|ICSH Receptors|Receptors, LH hCG|LH Receptors|Receptor, LH|Hormone Receptors, Luteinizing|Human Chorionic Gonadotropin Receptors|Receptors, hCG|Receptors, LH-hCG|Gonadotropin Receptors, Chorionic|Human Chorionic Gonadotropin Receptor|Receptor, Luteinizing Hormone|Chorionic Gonadotropin Receptors|LH Receptor|hCG Receptors | Receptors, LH |
C0290758 | null | steroidogenic acute regulatory protein | steroidogenic acute regulatory protein |
C0046725 | null | 17beta-Hydroxysteroid dehydrogenase|3beta-hydroxysteroid dehydrogenase (substance)|3 (or 17)-beta-hydroxysteroid dehydrogenase|17 beta-hydroxysteroid dehydrogenase|17beta-hydroxysteroid dehydrogenase|3beta-hydroxysteroid dehydrogenase|3,17-beta-HSDase|3 beta,17 beta-hydroxysteroid dehydrogenase|3beta-Hydroxysteroid dehydrogenase | 3 (or 17)-beta-hydroxysteroid dehydrogenase |
C0003805 | An enzyme that catalyzes the desaturation (aromatization) of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system. | Protein, CYP19|CYP 19|EC 1.14.14.1|estrogen synthase|AROM|CYP19 Protein|CYP19|Androstenedione Aromatase|aromatases|Cytochrome P 450 CYP19|Cytochrome P-450(AROM)|P450AROM|Cytochrome P450 19|Aromatase, Androstenedione|aromatase|Estrogen Synthase|Estrogen Synthetase|Cytochrome P-450 CYP19|Aromatase | Aromatase |
C0005889 | Liquid components of living organisms. | Fluid, Body|Body fluid, NOS|Body Fluid|body fluids substance|Body fluid|Portion of body fluid|Body Fluids and Substances|FLUID|body fluids|Body Fluid or Substance|Fluids, Body|Body fluid (substance)|body fluid|Body Fluids or Substances|Body Fluids|Body fluids | Body Fluids |
C0270612 | Any of various diseases affecting the white matter of the central nervous system. | White matter disease (disorder)|Diseases, White Matter|White Matter Disease|White Matter Diseases|Leucoencephalopathy|Leukoencephalopathies|leukoencephalopathies|White matter of brain syndrome, NOS|Brain syndrome, white matter|Leukoencephalopathy, NOS|White matter disease|leukoencephalopathy|brain disease matter white|Leukoencephalopathy (disorder)|Leukoencephalopathy|Disease, White Matter | Leukoencephalopathy |
C0006868 | null | Abuse, Cannabis|Cannabis abuse|abuse cannabis|Cannabis Abuse|cannabis abuse|Cannabis abuse (disorder) | Cannabis Abuse |
C0034793 | Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement. | Receptor, Complement|complement receptors|complement receptor|Complement Receptors|Receptors, Complement|Complement receptor|COMPLEMENT RECEPTORS|Complement receptor (substance)|Complement receptor site|Complement Receptor | Complement Receptor |
C1325690 | Coarse, bluish-black staining cytoplasmic granules, bounded by a plasma membrane and found in mast cells and basophils. Contents include histamine, heparin, chondroitin sulfates, chymase and tryptase. [GOC:jl, http://www.ijp-online.com/archives/1969/001/02/r0000-0000tc.htm, PMID:12360215] | null | mast cell granule |
C0010837 | Condensed areas of cellular material that may be bounded by a membrane. | Cytoplasmic granules|Cytoplasmic Granule|Cytoplasmic Granules|Granule, Cytoplasmic|granule|Cytoplasmic granule|Granules, Cytoplasmic|Cell granule | Cytoplasmic Granules |
C0054036 | A fungal metabolite which is a macrocyclic lactone exhibiting a wide range of antibiotic activity. | decumbin|Ascotoxin|ascotoxin|Cyanein|brefeldin A|cyanein|Decumbin|4H-Cyclopent(f)oxacyclotridecin-4-one,1,6,7,8,9,11a-beta,12,13,14,14a-alpha-decahydro-1-beta-13-alpha-dihydroxy-6-beta-methyl-|Synergisidin | Brefeldin A |
C0599958 | technique for the isolation of genomic or cDNAs on the basis of their biological activity in vivo; DNA expressing activity of interest transfected into cells, DNA then isolated by selection and cloning; requires no prior knowledge of DNA sequence or location. | null | expression cloning |
C0079600 | Subunits of the antigenic determinant that are most easily recognized by the immune system and thus most influence the specificity of the induced antibody. | Determinants, Immunodominant|Immunodominant Antigenic Determinants|Domains, Immunodominant|Regions, Immunodominant|Immunodominant Sites|Immunodominant Determinants|Immunodominant Regions|Sites, Immunodominant|Epitopes, Immunodominant|Determinants, Immunodominant Antigenic|Immunodominant Domains|Antigenic Determinants, Immunodominant | Immunodominant Epitopes |
C0085655 | Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9) | Polymyositis (disorder)|Neuromyositis|Myositides, Multiple|multiple myositis|Myositis, Multiple|Polymyositis|PM - Polymyositis|polymyositis|Multiple Myositis|Clinical polymyositis syndrome|Polymyositides|POLYMYOSITIS | Polymyositis |
C0004482 | An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) | AZATHIOPRINE|ATP|Azathioprinum|Azatioprina|6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine|AZTP|Azothioprine|6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine|Azamun|atps|6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine|1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-|Azathioprine-containing product|azaTHIOprine|Azathioprine (substance)|azothioprine|Azathioprine|azathioprine|AZA|Product containing azathioprine (medicinal product) | azathioprine |
C0025677 | An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. | 4-amino-10-methylfolic acid|4-Amino-4-deoxy-10-methylpteroyl-L-glutamic Acid|Methotrexate Methylaminopterin|MTX|alpha-methopterin|methylaminopterin|Methotrexate (substance)|METHOTREXATE|N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Product containing methotrexate (medicinal product)|mtx|L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-|4-amino-4-deoxy-10-methylpteroyl-L-glutamic acid|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic Acid|Amethopterin|Methotrexate|amethopterin|4-amino-N(10)-methylpteroylglutamic acid|Methotrexatum|methotrexate|Methotrexat|Alpha-Methopterin|Methotrexate-containing product|Metotrexato|MTX - methotrexate|4-Amino-10-methylfolic Acid|Méthotrexate|methotrexate methylaminopterin | methotrexate |
C0376495 | The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful. | Readministration|Retreatments|Retreatment|retreatment|Reapplication|Reintroduction | Retreatments |
C0007577 | Adherence of cells to surfaces or to other cells. | Cellular Adhesion|adhesion cell|Cell Adhesions|Cell Adhesion|adhesion cellular|Cell Adhesion Process|cellular adhesion|Cell adhesion|Adhesion, Cell|Adhesions, Cell|cell adhesion | Cell Adhesion |
C0542241 | The condition resulting from the spread of bacterial products (toxins) by the bloodstream. | TOXEMIA BACTERIAL|Bacterial Toxemia|toxemia|Toxemia | Bacterial Toxemia |
C0814048 | The measurement of physical and /or chemical characteristics of cells, or, by extension, of other biological particles. | cytometry|Cytometry | Cytometry |
C0010858 | Compounds that inhibit or prevent the proliferation of CELLS. | Cytostatics|cytostatic|cytostatics|Cytostatic Drugs | Cytostatic Agents |
C0235574 | null | Hemolysis, Intravascular|Intravascular hemolysis (finding)|HEMOLYSIS INTRAVASCULAR|Hemolyses, Intravascular|Intravascular Hemolyses|Intravascular hemolysis|Intravascular Hemolysis|intravascular hemolysis|Intravascular haemolysis|intravascular haemolysis | Intravascular hemolysis |
C0019189 | INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. | chronic hepatitis|Chronic hepatitis|hepatitis chronic|CH - Chronic hepatitis|CHRONIC HEPATITIS|Chronic hepatitis (disorder)|Chronic hepatitis, unspecified|Hepatitis, chronic|Chronic hepatitis, NOS|Chronic liver inflammation|Chronic Hepatitis | Hepatitis, Chronic |
C0015879 | Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. | Ferritins|Ferritin|ferritins|Ferritin (substance)|ferritin | Ferritin |
C0736268 | The tissue of the liver. It includes the hepatic lobules, hepatic sinusoids, perisinusoidal spaces, and portal triad. The hepatic lobules are composed of hepatocytes. | tissue liver|parenchyma liver|Structure of parenchyma of liver|Liver tissue|liver parenchyma|Hepatic Parenchyma|Liver tissue (substance)|liver tissue|Hepatic Tissue|liver tissues|Parenchyma of liver|Liver Tissue|hepatic parenchyma|Liver parenchyma|Hepatic parenchyma|Structure of parenchyma of liver (body structure) | Liver parenchyma |
C0267373 | Bleeding originating in the gastrointestinal tract. | intestine bleed|Intestinal bleeding|Intestinal haemorrhage|Intestinal haemorrhage, NOS|intestinal hemorrhage|intestinal haemorrhage|Intestinal Hemorrhage|intestinal bleeding|intestine bleeding|bleeding intestines|Intestinal hemorrhage (disorder)|Intestinal hemorrhage|bleeding intestine | Intestinal hemorrhage NOS |
C0014245 | Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body. | Endoscopy, NOS (-scopy)|ENDOSCOPY|Endoscopic Examination|endoscopy|Endoscopy (procedure)|Endoscopic Procedure|procedure endoscopy|Inspection using endoscope|Endoscopic|endoscopic procedure|Endoscopy, NOS|Endoscopy|endoscopies|endoscopy procedure | Endoscopy (procedure) |
C0023038 | Incision into the side of the abdomen between the ribs and pelvis. | Laparotomies|Laparotomy, NOS|laparotomy procedure|Opening of peritoneal cavity|explorative laparotomy|laparotomies|Coeliotomy|Laparotomy|Celiotomy|laparotomy|celiotomy|Opening of abdomen|Opening of peritoneum|Laparotomy (procedure)|Celiotomy, NOS | Laparotomy |
C0012804 | A pre-emergent herbicide. | 3-(3,4-Dichlorophenyl)-1,1-dimethylurea|Dichlorophenyl dimethyl urea|DCMU|Diuron|Urea, N'-(3,4-dichlorophenyl)-N,N-dimethyl-|Dichlorophenyl dimethyl urea (substance) | Diuron |
C0031006 | The delivery of chemotherapy to a specific tissue area that is excluded from the general circulation during the period of infusion, which allows for a high concentration of the drug in the tumour area as well as sparing of the rest of the body from the side effects of the drug. | isolation perfusion|Perfusion, in situ|Isolated Chemotherapeutic Perfusion|In situ perfusion (procedure)|In situ perfusion|isolated perfusion|perfusion, isolated | In situ perfusion |
C0001613 | The outer layer of the adrenal gland. It is derived from MESODERM and comprised of three zones (outer ZONA GLOMERULOSA, middle ZONA FASCICULATA, and inner ZONA RETICULARIS) with each producing various steroids preferentially, such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE. Adrenal cortex function is regulated by pituitary ADRENOCORTICOTROPIN. | Cortex glandulae suprarenalis|Adrenal cortex, NOS|Adrenal cortex structure (body structure)|Adrenal cortex structure|Cortical|Cortex, Adrenal|Adrenal cortex|Suprarenal cortex|Cortex (Glandula suprarenalis)|Adrenal Cortex|adrenal cortex|Cortex of Adrenal Gland|Cortex of suprarenal gland|Cortex of adrenal gland | Adrenal Cortex |
C0151468 | A benign, encapsulated tumor, arising from the follicular cells of the thyroid gland. It may be associated with thyroid hormone secretion but it does not have malignant characteristics. | Adenoma of Thyroid Gland|adenoma thyroid|Thyroid Gland Adenoma|Thyroid Adenomas|Thyroid Adenoma|Adenoma, Thyroid|Thyroid adenoma|Adenoma of the Thyroid|adenomas thyroid|follicular adenoma thyroid|Thyroid adenoma (disorder)|THYROID ADENOMA|ADENOMA, FOLLICULAR CELL, BENIGN|Thyroid follicular adenoma (disorder)|THYROID ADENOMA, FOLLICULAR|Adenoma of Thyroid|Adenoma of the Thyroid Gland|Thyroid follicular adenoma|ADENOMA THYROID|Thyroid Follicular Adenoma|thyroid adenoma|Follicular Adenoma of Thyroid|Adenomas, Thyroid|Thyroid Gland Follicular Adenoma|adenoma follicular thyroid|Follicular Adenoma of Thyroid Gland|Follicular Adenoma of the Thyroid|Follicular Adenoma|Follicular Adenoma of the Thyroid Gland|thyroid follicular adenoma | Thyroid Gland Follicular Adenoma |
C0454523 | null | Manual hyperinflation (procedure)|Bagging - manual hyperinflation | Manual hyperinflation |
C0231921 | null | Pulmonary function|function pulmonary|Pulmonary function (observable entity)|pulmonary function|pulmonary functions|PULMONARY FUNCTIONS | Pulmonary function |
C0080311 | The hemodynamic and electrophysiological action of the right HEART VENTRICLE. | Function, Right Ventricular|Right ventricular function|Functions, Right Ventricular|function right ventricular|right ventricular function|Ventricular Functions, Right|Right ventricular function (observable entity)|Right Ventricular Function|Right Ventricular Functions | Ventricular Function, Right |
C1038817 | A non taxonomic grouping of bacteria assigned to and including at least nine related species from the Burkholderia genus. | Burkholderia cepacia Complex|Burkholderia cepacia complex|Burkholderia cepacia complex (organism)|BURKHOLDERIA CEPACIA COMPLEX | Burkholderia cepacia complex |
C0031592 | An organothiophosphorus insecticide that has been used to control pig mange. | Phthalophos|Phosmet (substance)|PHOSMET|Phosmet|N-(Mercaptomethyl)phthalimide S-(O,O-dimethyl phosphorothionate)|Phosphorodithioic acid, S-((1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl) O,O-dimethyl ester | Phosmet |
C0031119 | The nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium. | peripheral nerves|NERVE, PERIPHERAL|PERIPHERAL NERVE STRUCTURES|PERIPHERAL NERVE|Peripheral nerve structure|Peripheral nerve structure (body structure)|Peripheral nerve tree|Nerves, Peripheral|Peripheral nerve|Peripheral nerve, NOS|peripheral nerve|Peripheral Nerve|Nerve, Peripheral|peripheral nerve structure|nerves peripheral|Peripheral Nerves | Peripheral Nerves |
C0337672 | null | nonsmoker|Non-smoker (finding)|non-smoker|smoker non|non smokers|non smoker|Non-smoker|nonsmokers | Non-smoker |
C0053396 | A carotenoid that is a precursor of VITAMIN A. Beta carotene is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (PORPHYRIA, ERYTHROPOIETIC). | Betacarotene (substance)|β-Karotin|beta Carotene preparation|beta carotene|all-trans-β-carotene|.BETA.-CAROTENE|Betacarotene|.beta.-carotene|Betacarotene-containing product|Trans-beta-carotene preparation|Beta-Carotene|.Beta.-Carotene|CAROTENE,BETA|Provitamin A|BETA CAROTENE|beta Carotene|Beta carotene|.Beta.-carotene|betacarotene|beta-Carotene|Carotene, beta|.BETA.-Carotene|CAROTENE, BETA|Product containing betacarotene (medicinal product)|.beta.-Carotene|beta-carotene|3,7,12,16-tetramethyl-1,18-bis(2,6,6-trimethyl-1-cyclohexenyl)-octadeca-1,3,5,7,9,11,13,15,17-nonaene|Beta-carotene|Beta Carotene | beta carotene |
C0206682 | An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed) | THYROID CANCER, FOLLICULAR CARCINOMA|Follicular carcinoma|Follicular thyroid carcinoma (disorder)|Well-Differentiated Follicular Carcinoma|Follicular adenocarcinoma, well differentiated (morphologic abnormality)|carcinomas follicular|Follicular Thyroid Carcinomas|Well-Differentiated Follicular Adenocarcinoma|Carcinomas, Follicular Thyroid|Follicular Carcinoma of the Thyroid|follicular thyroid cancer|Follicular adenocarcinoma|Follicular adenocarcinoma, pure follicle type|Follicular carcinoma, well differentiated type|Adenocarcinoma, Follicular|follicular carcinoma|thyroid follicular cancer|THYROID FOLLICULAR CARCINOMA|follicular carcinoma thyroid|Thyroid Carcinoma, Follicular|Adenocarcinomas, Follicular|Well-differentiated Follicular Carcinoma|THYROID CARCINOMA, FOLLICULAR|Follicular thyroid carcinoma|Carcinoma, Follicular Thyroid|follicular thyroid carcinoma|CARCINOMA, FOLLICULAR CELL, MALIGNANT|THYROID, CARCINOMA, FOLLICULAR|Thyroid Carcinomas, Follicular|Follicular Carcinoma|cancer follicular thyroid|Thyroid Gland Follicular Carcinoma|Follicular carcinoma, well differentiated|Follicular Cancer of Thyroid Gland|Follicular adenocarcinoma, well differentiated type|Well-differentiated Follicular Adenocarcinoma|Follicular Carcinoma of Thyroid Gland|Thyroid Follicular Carcinoma|Follicular Cancer of Thyroid|Follicular carcinoma, pure follicle type|Follicular Carcinoma of the Thyroid Gland|Follicular adenocarcinoma - well differentiated|FTC - follicular thyroid carcinoma|Follicular Cancer of the Thyroid|Follicular Thyroid Carcinoma|Follicular adenocarcinoma, NOS|adenocarcinoma thyroid|Follicular Adenocarcinomas|Follicular carcinoma - well differentiated|Follicular Adenocarcinoma|FTC|Follicular Thyroid Gland Carcinoma|Follicular adenocarcinoma, well differentiated|Follicular Carcinoma of Thyroid|Follicular adenocarcinoma (morphologic abnormality)|Thyroid Gland Follicular Cancer|Follicular Cancer of the Thyroid Gland|Follicular Thyroid Cancer|carcinoma follicular thyroid|carcinoma follicular|Follicular carcinoma, NOS|thyroid follicular carcinoma | Follicular thyroid carcinoma |
C0549473 | Cancer that forms in the thyroid gland (an organ at the base of the throat that makes hormones that help control heart rate, blood pressure, body temperature, and weight). Four main types of thyroid cancer are papillary, follicular, medullary, and anaplastic thyroid cancer. The four types are based on how the cancer cells look under a microscope. | Cancer of the Thyroid|Cancers, Thyroid|Thyroid Gland Carcinoma|Carcinoma of Thyroid|Cancer, Thyroid|Thyroid Carcinoma|Carcinoma, Thyroid|Thyroid Cancers|Carcinoma of the Thyroid|thyroid carcinoma|Thyroid cancer|Thyroid cancer, NOS|thyroid cancer|Thyroid carcinoma|Carcinoma of the Thyroid Gland|Thyroid Cancer|Cancer of Thyroid|THYROID CARCINOMA|Carcinomas, Thyroid|Thyroid Carcinomas|thyroid gland carcinoma|carcinoma thyroid|CARCINOMA OF THYROID|CARCINOMA THYROID|Carcinoma of Thyroid Gland|Head and Neck Cancer, Thyroid|carcinoma thyroid gland|Thyroid gland--Cancer|carcinoma of thyroid|Thyroid Gland Cancer | Thyroid carcinoma |
C0227435 | null | Digestive organs|digestive organs|digestive organ|Digestive organ structure (body structure)|Digestive organ|Digestive organs, NOS|DIGESTIVE ORGANS|Digestive organ structure | Digestive organ structure |
C0086692 | A growth that is not cancer. It does not invade nearby tissue or spread to other parts of the body. | Neoplasm, benign|Neoplasms, Benign|Unclassified tumor, benign|Benign Tumors|nonmalignant neoplasm|benign neoplasm|Benign neoplasm|Benign neoplastic disease|Benign Neoplasms|benign tumour|Benign tumor morphology|NONMALIGNANT TUMORS|Neoplasm, Benign|Benign neoplasm of unspecified site|Benign Tumor|benign tumors|Benign neoplasm, site unspecified|Tumors, Benign|Benign neoplasms|Benign neoplastic disease (disorder)|Benign tumour morphology|nonmalignant tumor|Benign tumor or blood disorder|benign neoplasms|benign tumor|Benign Unclassifiable Tumor|BENIGN TUMOR|BENIGN NEOPLASMS|Neoplastic disease, benign|benign tumours|nonmalignant tumors|NEOPLASM, BENIGN|Neoplasm, benign (morphologic abnormality)|Noncancerous tumors|Tumour, benign|Benign Neoplasm|Unclassified tumour, benign|Tumor, benign | Benign Neoplasm |
C0333980 | Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen. | nodular focal hyperplasia|Focal nodular hyperplasia|Hyperplasia, Focal Nodular|focal hyperplasia nodular|nodular hyperplasia focal|Focal Nodular Hyperplasias|Hyperplasias, Focal Nodular|Focal nodular hyperplasia (morphologic abnormality)|focal nodular hyperplasia | Focal Nodular Hyperplasia |
C0041967 | A tube that transports URINE from the URINARY BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM. | Urethral|Urethra|Urethral structure|Urethral structure (body structure)|urethra|Urethra, NOS|Urethras|Urethral (qualifier value)|urethras|urethro|urethr(o)-|urethral|urethral structure|Urethro-|URETHRA | Urethra |
C0042024 | Involuntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE. | URINATION INVOLUNTARY|Unable to control bladder|loss of bladder control|bladder incontinent|Urinary Incontinence|urinary incontinence|BLADDER INCONTINENCE|Urine incontinence|incontinent of urine|leaking urine|UI - Urinary incontinence|urine leaking|URINE INCONTINENCE|incontinent bladder|Bladder continence, absence|INCONTINENCE URINARY|Enuresis|bladder incontinence|Bladder: incontinent|Urine Incontinence|urinary incontinences|Incontinence of urine|Unable to hold urine|Weak bladder|Urinary incontinence|URINARY BLADDER INCONTINENCE|urine incontinent|weak bladder|Bladder incontinence|Unable to prevent bladder emptying|Lack of bladder control|Loss of bladder control|Unable to hold fluids|Incontinence, Urinary|Leaking of urine|Involuntary urination|Urinary incontinence (finding)|involuntary urination|urine leak|urine incontinence|URINARY INCONTINENCE|Urinary incontinence, unspecified|Absence of bladder continence|bladder control loss | Urinary Incontinence |
C0040128 | Pathological processes involving the THYROID GLAND. | DISEASES OF THE THYROID GLAND|THYROID DISORDER|Thyroid disorders|Unspecified disorder of thyroid|Disease of thyroid gland, NOS|Thyroid Gland Disease|Thyroid disorder|thyroid disorders|THYROID DISEASE|Diseases of Thyroid Gland|Thyroid Gland Disorder|Disease, Thyroid|Thyroid disorder, NOS|Disorder of thyroid gland (disorder)|thyroid abnormal|THYROID DISEASE, NOS|DISORDER THYROID|thyroid gland disorders|Diseases, Thyroid|HYPOTHYROIDISM, HYPERTHYROIDISM AND OTHER DISORDERS|diseases of the thyroid gland|Thyroid Diseases|Disease of thyroid gland|thyroid gland diseases|Thyroid abnormalities|Disorder of thyroid gland|thyroid disease|abnormal thyroid|DISORDERS OF THYROID GLAND|Disorder of thyroid gland, NOS|thyroid disorder|Thyroid gland--Diseases|Thyroid disease|thyroid gland disorder|Thyroid Gland Disorders|thyroid diseases|Thyroid Disease|thyroid gland disease|Thyroid Gland Diseases | Thyroid Diseases |
C0034898 | Branches of the vagus (tenth cranial) nerve. The recurrent laryngeal nerves originate more caudally than the superior laryngeal nerves and follow different paths on the right and left sides. They carry efferents to all muscles of the larynx except the cricothyroid and carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions. | Recurrent Laryngeal Nerves|recurrent laryngeal nerve|Nerves, Recurrent Laryngeal|Structure of recurrent laryngeal nerve|Structure of recurrent laryngeal nerve (body structure)|Nervus laryngeus recurrens|recurrent laryngeal nerves|Nerve, Recurrent Laryngeal|Laryngeal Nerves, Recurrent|Recurrent laryngeal nerve|RLN - Recurrent laryngeal nerve|Laryngeal Nerve, Recurrent | Recurrent Laryngeal Nerve |
C1280082 | null | Entire right pleural cavity (body structure)|Entire right pleural cavity | Entire right pleural cavity |
C0034196 | The region of the STOMACH at the junction with the DUODENUM. It is marked by the thickening of circular muscle layers forming the pyloric sphincter to control the opening and closure of the lumen. | Pyloric region of stomach|Pylorus|Pyloric|Pyloric structure of stomach (body structure)|STOMACH, PYLORUS|pyloric|Pyloric structure of stomach|Pars pylorica gastricae|Pyloric part of stomach|Pylorus structure|pyloro|pylorus|Pyloro- | Pylorus |
C0003484 | The aorta from the DIAPHRAGM to the bifurcation into the right and left common iliac arteries. | abdominal aorta|Abdominal Aorta|Descending abdominal aorta|Abdominal aorta structure|ABDOMINAL AORTA|Aorta, Abdominal|Abdominal aorta|aorta abdominal|Abdominal Aortas|Abdominal aorta structure (body structure)|Aortas, Abdominal|Aorta abdominalis|Pars abdominalis aortae|Abdominal part of aorta | Abdominal aorta structure |
C0005403 | Retrograde bile flow. Reflux of bile can be from the duodenum to the stomach (DUODENOGASTRIC REFLUX); to the esophagus (GASTROESOPHAGEAL REFLUX); or to the PANCREAS. | Reflux, Bile|reflux bile|Bile reflux|bile reflux|Bile reflux (finding) | Bile Reflux |
C0013299 | Retrograde flow of duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the STOMACH. | Duodeno Gastric Reflux|Duodenal Refluxs|Duodenogastric reflux|duodenogastric reflux|Reflux, Duodenal|Duodeno-Gastric Reflux|Reflux, Duodeno-Gastric|duodenal reflux|DGR - Duodenogastric reflux|Duodenal Reflux|Duodenogastric reflux (finding)|Reflux, Duodenogastric | Duodenogastric Reflux |
C0559234 | null | reflux esophageal|Oesophageal reflux observation|Oesophageal reflux finding|Esophageal reflux observation|Esophageal reflux|Esophageal reflux finding (finding)|Oesophageal reflux|esophageal reflux|Esophageal reflux finding|oesophageal reflux | Esophageal reflux observation |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.